Physiological involvement of placental endothelin-1 and prostaglandin F2α in uteroplacental circulatory disturbance in pregnant rats exposed to heat stress

Hiroyuki Nakamura, Ichiyo Matsuzaki, Kotaro Hatta, Keiki Ogino

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Several studies suggest that heat stress affects placental functions including uteroplacental circulation, subsequently leading to pregnancy failure and birth weight reduction. To clarify the involvement of endothelin and placental prostaglandin (PG) systems in the uteroplacental circulation during heat stress, we examined the effects of i.v. administration of the endothelin receptor antagonist bosentan and the cyclooxygenase inhibitor indomethacin on uteroplacental blood flow and on placental PGE2 and PGF levels and their 13,14-dyhydro-15-keto-metabolites (PGEM and PGFM, respectively) in heat-exposed or non-heat-exposed pregnant rats. The administration of bosentan or indomethacin did not change uteroplacental blood flow in non-heat-exposed pregnant rats. In contrast, heat reduced uteroplacental blood flow in pregnant rats, but the reduction was reversed by the administration of bosentan or indomethacin before heat exposure. Heat did not change placental PGE2 or PGEM levels, but in pregnant rats it increased placental PGF, and PGFM levels, which were reversed by bosentan or indomethacin. Our results suggest that the activation of placental endothelin receptor and PGF systems are involved in the uteroplacental circulatory disturbances produced by heat. PGF systems activated by heat may be involved in the vasoconstricting effects of endothelin-A and -B receptors during heat exposure.

Original languageEnglish
Pages (from-to)225-230
Number of pages6
JournalCanadian Journal of Physiology and Pharmacology
Volume82
Issue number4
DOIs
Publication statusPublished - Apr 2004
Externally publishedYes

Fingerprint

Dinoprost
Endothelin-1
Hot Temperature
Indomethacin
Placental Circulation
Prostaglandins F
Dinoprostone
Endothelin B Receptors
Endothelin A Receptors
Endothelin Receptors
Cyclooxygenase Inhibitors
Endothelins
Birth Weight
Prostaglandins
Weight Loss
Pregnancy
bosentan

Keywords

  • Blood flow
  • Endothelin
  • Placenta
  • Pregnancy
  • Prostaglandin

ASJC Scopus subject areas

  • Physiology
  • Pharmacology

Cite this

Physiological involvement of placental endothelin-1 and prostaglandin F2α in uteroplacental circulatory disturbance in pregnant rats exposed to heat stress. / Nakamura, Hiroyuki; Matsuzaki, Ichiyo; Hatta, Kotaro; Ogino, Keiki.

In: Canadian Journal of Physiology and Pharmacology, Vol. 82, No. 4, 04.2004, p. 225-230.

Research output: Contribution to journalArticle

@article{08381041008048af8a107dc5af52e191,
title = "Physiological involvement of placental endothelin-1 and prostaglandin F2α in uteroplacental circulatory disturbance in pregnant rats exposed to heat stress",
abstract = "Several studies suggest that heat stress affects placental functions including uteroplacental circulation, subsequently leading to pregnancy failure and birth weight reduction. To clarify the involvement of endothelin and placental prostaglandin (PG) systems in the uteroplacental circulation during heat stress, we examined the effects of i.v. administration of the endothelin receptor antagonist bosentan and the cyclooxygenase inhibitor indomethacin on uteroplacental blood flow and on placental PGE2 and PGF 2α levels and their 13,14-dyhydro-15-keto-metabolites (PGEM and PGFM, respectively) in heat-exposed or non-heat-exposed pregnant rats. The administration of bosentan or indomethacin did not change uteroplacental blood flow in non-heat-exposed pregnant rats. In contrast, heat reduced uteroplacental blood flow in pregnant rats, but the reduction was reversed by the administration of bosentan or indomethacin before heat exposure. Heat did not change placental PGE2 or PGEM levels, but in pregnant rats it increased placental PGF2α, and PGFM levels, which were reversed by bosentan or indomethacin. Our results suggest that the activation of placental endothelin receptor and PGF2α systems are involved in the uteroplacental circulatory disturbances produced by heat. PGF 2α systems activated by heat may be involved in the vasoconstricting effects of endothelin-A and -B receptors during heat exposure.",
keywords = "Blood flow, Endothelin, Placenta, Pregnancy, Prostaglandin",
author = "Hiroyuki Nakamura and Ichiyo Matsuzaki and Kotaro Hatta and Keiki Ogino",
year = "2004",
month = "4",
doi = "10.1139/y04-011",
language = "English",
volume = "82",
pages = "225--230",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "4",

}

TY - JOUR

T1 - Physiological involvement of placental endothelin-1 and prostaglandin F2α in uteroplacental circulatory disturbance in pregnant rats exposed to heat stress

AU - Nakamura, Hiroyuki

AU - Matsuzaki, Ichiyo

AU - Hatta, Kotaro

AU - Ogino, Keiki

PY - 2004/4

Y1 - 2004/4

N2 - Several studies suggest that heat stress affects placental functions including uteroplacental circulation, subsequently leading to pregnancy failure and birth weight reduction. To clarify the involvement of endothelin and placental prostaglandin (PG) systems in the uteroplacental circulation during heat stress, we examined the effects of i.v. administration of the endothelin receptor antagonist bosentan and the cyclooxygenase inhibitor indomethacin on uteroplacental blood flow and on placental PGE2 and PGF 2α levels and their 13,14-dyhydro-15-keto-metabolites (PGEM and PGFM, respectively) in heat-exposed or non-heat-exposed pregnant rats. The administration of bosentan or indomethacin did not change uteroplacental blood flow in non-heat-exposed pregnant rats. In contrast, heat reduced uteroplacental blood flow in pregnant rats, but the reduction was reversed by the administration of bosentan or indomethacin before heat exposure. Heat did not change placental PGE2 or PGEM levels, but in pregnant rats it increased placental PGF2α, and PGFM levels, which were reversed by bosentan or indomethacin. Our results suggest that the activation of placental endothelin receptor and PGF2α systems are involved in the uteroplacental circulatory disturbances produced by heat. PGF 2α systems activated by heat may be involved in the vasoconstricting effects of endothelin-A and -B receptors during heat exposure.

AB - Several studies suggest that heat stress affects placental functions including uteroplacental circulation, subsequently leading to pregnancy failure and birth weight reduction. To clarify the involvement of endothelin and placental prostaglandin (PG) systems in the uteroplacental circulation during heat stress, we examined the effects of i.v. administration of the endothelin receptor antagonist bosentan and the cyclooxygenase inhibitor indomethacin on uteroplacental blood flow and on placental PGE2 and PGF 2α levels and their 13,14-dyhydro-15-keto-metabolites (PGEM and PGFM, respectively) in heat-exposed or non-heat-exposed pregnant rats. The administration of bosentan or indomethacin did not change uteroplacental blood flow in non-heat-exposed pregnant rats. In contrast, heat reduced uteroplacental blood flow in pregnant rats, but the reduction was reversed by the administration of bosentan or indomethacin before heat exposure. Heat did not change placental PGE2 or PGEM levels, but in pregnant rats it increased placental PGF2α, and PGFM levels, which were reversed by bosentan or indomethacin. Our results suggest that the activation of placental endothelin receptor and PGF2α systems are involved in the uteroplacental circulatory disturbances produced by heat. PGF 2α systems activated by heat may be involved in the vasoconstricting effects of endothelin-A and -B receptors during heat exposure.

KW - Blood flow

KW - Endothelin

KW - Placenta

KW - Pregnancy

KW - Prostaglandin

UR - http://www.scopus.com/inward/record.url?scp=3042831706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042831706&partnerID=8YFLogxK

U2 - 10.1139/y04-011

DO - 10.1139/y04-011

M3 - Article

C2 - 15181460

AN - SCOPUS:3042831706

VL - 82

SP - 225

EP - 230

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 4

ER -